From: RETRACTED ARTICLE: The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer
Tumor volumes (mm3)
Drug-before
Drug-after
Control group
234.83 ± 28
1452.83 ± 61.47
Group-1
230.17 ± 31.66
144 ± 37.65**
Group-2
224.83 ± 28
142.33 ± 31.4**
Group-3
233.67 ± 29.37
138.83 ± 31.43**